Rosiglitazone and pulmonary oedema: an acute dose-dependent effect on human endothelial cell permeability

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Diabetologia

• Publication date

  2003-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00125-002-1008-1PMID 12627329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II

  2002cited by this paper
• Pulmonary Edema Associated with Rosiglitazone and Troglitazone

  2001cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.

  2000cited by this paper
• Peroxisome Proliferator-Activated Receptor-γ Agonists Increase Vascular Endothelial Growth Factor Expression in Human Vascular Smooth Muscle Cells

  2000cited by this paper
• Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2 *

  1999cited by this paper
• The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

  1999cited by this paper
• Pulmonary edema associated with troglitazone therapy.

  1999cited by this paper
• Significant weight gain with rezulin therapy.

  1999cited by this paper
• VEGF induces hyperpermeability by a direct action on endothelial cells.

  1998cited by this paper
• VEGF induces hyperpermeability by a direct action on endothelial cells.

  1998influential reference
• Nitric oxide and endothelial permeability.

  1997cited by this paper
• Dual effect of insulin on plasma volume and transcapillary albumin transport

  1992cited by this paper

• Etiology of Drug-Induced Edema: A Review of Dihydropyridine, Thiazolidinedione, and Other Medications Causing Edema

  2024cites this paper
• Dose-Dependent Effects of Radiation on Mitochondrial Morphology and Clonogenic Cell Survival in Human Microvascular Endothelial Cells

  2023cites this paper
• Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials

  2022cites this paper
• Aqueous extract from Mangifera indica Linn. (Anacardiaceae) leaves exerts long-term hypoglycemic effect, increases insulin sensitivity and plasma insulin levels on diabetic Wistar rats

  2020cites this paper
• IDENTIFICATION OF NOVEL PPARγ MODULATORS / PARTIAL AGONISTS THROUGH VIRTUAL SCREENING WORKFLOW

  2019cites this paper
• A role of Ficus species in the management of diabetes mellitus: A review.

  2018cites this paper
• Anti-Diabetic Potential of Selected Indian Traditional Medicinal Plants – An Updated Review

  2016cites this paper
• Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?

  2016influential citation
• Antidiabetic therapeutics from natural source: A systematic review

  2014cites this paper
• Human in vivo studies on the non-glycaemic effects of thiazolidinedione derivatives

  2014cites this paper
• The importance of synthetic drugs for type 2 diabetes drug discovery

  2013cites this paper
• Design and in vitro Evaluation of Gastroretentive Floating Drug Delivery System of Rosigilitazone Maleate

  2013cites this paper
• Diagnosis of Systemic Inflammation Using Transendothelial Electrical Resistance and Low-Temperature Co-fired Ceramic Materials

  2013cites this paper
• Acute Rosiglitazone Treatment during Reperfusion after Hyperglycemic Stroke is Neuroprotective Not Vascular Protective

  2012cites this paper
• Highlights from the latest articles in diabetes pharmacogenomics.

  2012cites this paper
• Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes.

  2012cites this paper
• The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

  2012cites this paper
• Floating Hollow Microspheres as Gastroretentive Drug Delivery System for Rosiglitazone Maleate

  2011cites this paper
• FEASIBILITY OF ROSIGLITAZONE MALEATE FOR TRANSDERMAL DELIVERY

  2011cites this paper
• Genetic predisposition and nongenetic risk factors of thiazolidinedione-related edema in patients with type 2 diabetes

  2011cites this paper
• Rotational co‐culture of clonal β‐cells with endothelial cells: effect of PPAR‐γ agonism in vitro on insulin and VEGF secretion

  2011cites this paper
• Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator-activated receptor-gamma agonist use in prediabetes.

  2010cites this paper
• The MAPK-dependent regulation of the Jagged/Notch gene expression by VEGF, bFGF or PPAR gamma mediated angiogenesis in HUVEC.

  2010cites this paper
• Effects of Chronic PPAR-Agonist Treatment on Cardiac Structure and Function, Blood Pressure, and Kidney in Healthy Sprague-Dawley Rats

  2009cites this paper
• The role of human CYP 2 C 8 and CYP 2 C 9 variants in pioglitazone metabolism in vitro

  2009cites this paper
• Multiunit Floating Drug Delivery System of Rosiglitazone Maleate: Development, Characterization, Statistical Optimization of Drug Release and In Vivo Evaluation

  2009cites this paper
• The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro.

  2009cites this paper
• Thiazolidinediones and Congestive Heart Failure: A Judicious Balance of Risks and Benefits

  2009cites this paper
• Insulin resistance and impaired functional vasodilation in obese Zucker rats.

  2008cites this paper
• Chronic Rosiglitazone Therapy Normalizes Expression of ACE1, SCD1 and other Genes in the Kidney of Obese Zucker Rats as Determined by Microarray Analysis

  2008cites this paper
• Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.

  2008cites this paper
• Endocrine Disorders and the Heart

  2007cites this paper
• Microvascular Permeability in Diabetes and Insulin Resistance

  2007cites this paper
• Effects of rosiglitazone on plasma brain natriuretic peptide levels and myocardial performance index in patients with type 2 diabetes mellitus

  2007cites this paper
• Immune modulating effects of B-glucan, fish oil and conjugated linoleic acid

  2007cites this paper
• Safety issues and prospects for future generations of PPAR modulators.

  2007cites this paper
• Proton and sodium MRI assessment of fluid level in calf tissue

  2006cites this paper
• Adipose‐specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARγ agonist's effects on edema and weight gain

  2006cites this paper
• Reduction in hematocrit level after pioglitazone treatment is correlated with decreased plasma free testosterone level, not hemodilution, in women with polycystic ovary syndrome

  2006cites this paper
• Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance.

  2006cites this paper
• Acute Pulmonary Edema Due to Rosiglitazone Use in a Patient With Diabetes Mellitus

  2006cites this paper
• Rosiglitazone Regulates ENaC and Na-K-2Cl Cotransporter (NKCC2) Abundance in the Obese Zucker Rat

  2006cites this paper
• Delayed onset of rosiglitazone-induced pulmonary oedema.

  2006cites this paper
• Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects.

  2006cites this paper
• Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation : novel mechanism for PPAR agonist ’ s effects on edema and weight gain

  2006cites this paper
• Chapter 16 Looking to the future as keepers of the dam

  2005cites this paper
• Chapter 15 Advances in protection of endothelial barrier function

  2005cites this paper
• Diabetes mellitus and its treatment

  2005cites this paper
• Effects of Gemfibrozil, Itraconazole, and Their Combination on the Pharmacokinetics of Pioglitazone

  2005cites this paper
• CHARACTERIZATION OF CYTOCHROME P450 2C8 ACTIVITY IN VIVO: PHARMACOGENETIC AND PHARMACOKINETIC STUDIES OF ROSIGLITAZONE METABOLISM

  2005cites this paper
• The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects.

  2005cites this paper
• Diabetes mellitus type 2, een epidemie met wereldwijde dimensies

  2004cites this paper
• Development of an in vitro model for vascular injury with human endothelial cells.

  2004cites this paper
• Protein kinase C-beta inhibition and diabetic microangiopathy: effects on endothelial permeability responses in vitro.

  2004cites this paper
• Combined Thiazolidinedione-Insulin Therapy

  2004cites this paper
• Insulin Edema in the Twenty-first Century: Review of the Existing Literature

  2004cites this paper
• Results of a randomized, double-blind, placebo-controlled study administering glimepiride to patients with type 2 diabetes mellitus inadequately controlled with rosiglitazone monotherapy.

  2004cites this paper
• Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects.

  2004cites this paper
• The possible role of peroxisome proliferator-activated receptor gamma in heart failure.

  2004cites this paper
• Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone

  2004cites this paper
• Thiazolidinediones and congestive heart failure—exacerbation or new onset of left ventricular dysfunction?

  2004cites this paper
• Drug-Induced Respiratory Disease in Connective Tissue Diseases

  2004cites this paper
• Rosiglitazone increases extravasation of macromolecules and endothelial nitric oxide synthase in skeletal muscles of the fructose-fed rat model.

  2004cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• Rosiglitazone Activates Renal Sodium- and Water-Reabsorptive Pathways and Lowers Blood Pressure in Normal Rats

  2004cites this paper
• Current literature in diabetes

  2003cites this paper
• Gemfibrozil considerably increases the plasma concentrations of rosiglitazone

  2003cites this paper
• Current literature in diabetes.

  2003cites this paper
• Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.

  2003cites this paper
• Cardiovascular disease in patients who have diabetes.

  2003cites this paper
• Develop-ment of an In Vitro Model for Vascular Iniury " , ith Human Endothelial Cells

  year unknowncites this paper